Our results clearly demonstrated that WDR79 knockdown in NSCLC cells increased the level of Bax, while concomitantly decreasing Bcl‐2 levels, which lowered the ratio of Bcl‐2 to Bax. Here, WRAP53 is linked to non-small cell lung carcinoma.